Aptose Biosciences logo

Aptose Biosciences Share Price Today

(NASDAQ: APTO)

Aptose Biosciences share price is $2.98 & ₹259.17 as on 6 Mar 2025, 2.30 'hrs' IST

$2.98

0.39

(15.06%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Aptose Biosciences share price in Dollar and Rupees. Guide to invest in Aptose Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aptose Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Aptose Biosciences share price movements

  • Today's Low: $2.58
    Today's High: $2.99

    Day's Volatility :13.71%

  • 52 Weeks Low: $2.39
    52 Weeks High: $54.56

    52 Weeks Volatility :95.61%

Aptose Biosciences (APTO) Returns

PeriodAptose Biosciences IncIndex (Russel 2000)
3 Months
-48.77%
0.0%
6 Months
-73.75%
0.0%
1 Year
-94.05%
0.0%
3 Years
-99.38%
-11.6%

Aptose Biosciences (APTO) Key Statistics

in dollars & INR

Previous Close
$2.59
Open
$2.64
Today's High
$2.99
Today's Low
$2.5801
Market Capitalization
$5.6M
Today's Volume
$96.4K
52 Week High
$54.561
52 Week Low
$2.3937
Revenue TTM
$0.0
EBITDA
$-36.2M
Earnings Per Share (EPS)
$-80.22
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-694.13%

How to invest in Aptose Biosciences Stock (APTO) from India?

It is very easy for Indian residents to invest directly in Aptose Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aptose Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aptose Biosciences or APTO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aptose Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aptose Biosciences shares which would translate to 0.292 fractional shares of Aptose Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aptose Biosciences, in just a few clicks!

Returns in Aptose Biosciences (APTO) for Indian investors in Rupees

The Aptose Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aptose Biosciences investment value today

Current value as on today

₹10,897

Returns

₹89,103

(-89.1%)

Returns from Aptose Biosciences Stock

₹94,052 (-94.05%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Aptose Biosciences (APTO)

1081.82%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Aptose Biosciences Shares from India has grown by 1081.82% over the past 30 days, indicating increased transactional activity.

317%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Aptose Biosciences Stock from India on INDmoney has increased by 317% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Aptose Biosciences

  • Bleichroeder LP

    3.89%

  • Sigma Planning Corp

    1.09%

  • DRW Securities, LLC

    0.92%

  • UBS Group AG

    0.09%

  • HRT FINANCIAL LLC

    0.07%

  • Annandale Capital, LLC

    0.04%

Analyst Recommendation on Aptose Biosciences

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Aptose Biosciences(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Aptose Biosciences Stock (APTO)

What analysts predicted

Upside of 1913.43%

Target:

$60.00

Current:

$2.98

Insights on Aptose Biosciences Stock (Ticker Symbol: APTO)

  • Price Movement

    In the last 1 month, APTO stock has moved down by -46.4%
  • APTO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 160.6%
  • APTO vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 151.0%

Aptose Biosciences Technicals Summary

Sell

Neutral

Buy

Aptose Biosciences is currently in a neutral trading position according to technical analysis indicators.

Aptose Biosciences (APTO) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aptose Biosciences Inc logo
-44.85%
-73.75%
-94.05%
-99.38%
-99.91%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aptose Biosciences Inc logo
NA
NA
0.0
-42.84
-6.94
-1.42
NA
-14.04
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aptose Biosciences Inc logo
Buy
$5.6M
-99.91%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Aptose Biosciences

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in myeloid malignancies, such as acute myeloid leukemia and the higher risk myelodysplastic syndromes; and luxeptinib (CG-806), a potent oral small molecule, which is in Phase 1 a/b clinical trial in patients with relapsed or refractory B cell malignancies, including chronic lymphocytic leukemia, small lymphocytic lymphoma, and certain non-Hodgkin's lymphomas, as well as relapsed or refractory acute myeloid leukemia. It has license agreements with CrystalGenomics Invites Co. Ltd. to research, develop, and commercialize luxeptinib; with National Cancer Institute for the clinical development of tuspetinib; and Hanmi Pharmaceutical Co Ltd. to research, develop, and commercialize tuspetinib. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.
Organization
Aptose Biosciences
Employees
35
CEO
Dr. William G. Rice Ph.D.
Industry
Health Technology

Management People of Aptose Biosciences

NameTitle
Dr. William G. Rice Ph.D.
Chairman, President & CEO
Mr. Fletcher Payne
Senior VP, CFO, Chief Business Officer & Secretary
Dr. Rafael Bejar M.D., Ph.D.
Senior VP & Chief Medical Officer
Dr. Marc Wiles Ph.D.
Senior Vice President of Regulatory Affairs

Important FAQs about investing in APTO Stock from India :

What is Aptose Biosciences share price today?

Aptose Biosciences share price today stands at $2.98, Open: $2.64 ; Previous Close: $2.59 ; High: $2.99 ; Low: $2.58 ; 52 Week High: $54.56 ; 52 Week Low: $2.39.

The stock opens at $2.64, after a previous close of $2.59. The stock reached a daily high of $2.99 and a low of $2.58, with a 52-week high of $54.56 and a 52-week low of $2.39.

Can Indians buy Aptose Biosciences shares?

Yes, Indians can invest in the Aptose Biosciences (APTO) from India.

With INDmoney, you can buy Aptose Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aptose Biosciences at zero transaction cost.

How can I buy Aptose Biosciences shares from India?

It is very easy to buy Aptose Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aptose Biosciences (APTO) be purchased?

Yes, you can buy fractional shares of Aptose Biosciences with INDmoney app.

What are the documents required to start investing in Aptose Biosciences stocks?

To start investing in Aptose Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aptose Biosciences Stock (APTO)?

Today’s highest price of Aptose Biosciences (APTO) is $2.99.

Today’s lowest price of Aptose Biosciences (APTO) is $2.58.

What is today's market capitalisation of Aptose Biosciences?

Today's market capitalisation of Aptose Biosciences APTO is 5.6M

What is the 52 Week High and Low Range of Aptose Biosciences Stock (APTO)?

  • 52 Week High

    $54.56

  • 52 Week Low

    $2.39

What are the historical returns of Aptose Biosciences (APTO)?

  • 1 Month Returns

    -44.85%

  • 3 Months Returns

    -73.75%

  • 1 Year Returns

    -94.05%

  • 5 Years Returns

    -99.91%

Who is the Chief Executive Officer (CEO) of Aptose Biosciences ?

Dr. William G. Rice Ph.D. is the current Chief Executive Officer (CEO) of Aptose Biosciences.